The Kenya Medical Supplies Authority (Kemsa) has appointed a second acting chief executive officer in a span of 16 months amid a restructuring plan at the scandal-hit agency.
The changes will see John Kabuchi, who is also the chairman of the Covid-19 vaccines procurement and logistics committee take over as the acting CEO from Edward Njoroge effective December 28, 2021.
